GRESHAM FINANCIAL LIMITED
Company number 04482993 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: GRESHAM FINANCIAL LIMITED
1. Financial Health Score: A-
Explanation: GRESHAM FINANCIAL LIMITED exhibits robust financial health with excellent liquidity, consistent profitability, and minimal leverage. The company has maintained a strong balance sheet over its 23-year history, with net assets growing steadily from £218,244 in 2016 to £309,730 in 2025. The slight deduction from an "A" grade reflects concerns about the composition of certain balance sheet items and minimal capital expenditure that may impact future competitiveness.
2. Key Vital Signs
💓 Liquidity Pulse - Excellent
| Metric | 2025 | 2024 | Interpretation |
|---|---|---|---|
| Current Ratio | 3.93:1 | 3.29:1 | Exceptionally healthy – well above the 1.5:1 benchmark |
| Quick Ratio | 3.92:1 | 3.28:1 | Strong – can cover short-term obligations without selling stock |
| Cash as % of Current Assets | 81.1% | 62.8% | Significant cash concentration |
Diagnosis: The patient has excellent "blood flow" – cash reserves of £312,371 have increased by 70% year-on-year, providing a substantial buffer against any financial shock. This is akin to having excellent cardiovascular fitness.
🏥 Leverage & Solvency - Healthy
| Metric | 2025 | 2024 | Interpretation |
|---|---|---|---|
| Debt-to-Equity Ratio | 0.32:1 | 0.36:1 | Low leverage – declining, which is positive |
| Total Liabilities to Total Assets | 25.4% | 30.4% | Conservative – less than a third of assets are funded by debt |
| Net Assets | £309,730 | £248,825 | Strong equity base growing by 24.5% |
Diagnosis: The company carries minimal "financial weight" relative to its size. The elimination of the hire purchase liability (£24,061 to £0) is particularly positive – like clearing a chronic condition.
📈 Profitability & Growth - Good
| Metric | 2025 | 2024 | Interpretation |
|---|---|---|---|
| Retained Earnings Growth | £60,905 | - | Profit for the year retained in the business |
| Net Asset Growth | 24.5% | - | Strong organic growth |
| 5-Year Net Asset CAGR | ~4.5% | - | Consistent long-term growth |
Diagnosis: The company is "well-nourished" with consistent profitability. The profit of approximately £60,905 (derived from the movement in retained earnings) represents a healthy return on the equity employed.
⚠️ Asset Composition - Monitor
| Item | 2025 | 2024 | Concern Level |
|---|---|---|---|
| Other Debtors | £68,420 | £99,682 | Medium – decreased but still 17.8% of total assets |
| Other Creditors | £25,947 | £1,524 | Medium – significant increase warrants investigation |
| Fixed Assets | £29,982 | £60,554 | Low – heavy depreciation with minimal reinvestment (£90) |
Diagnosis: The "other debtors" and sudden increase in "other creditors" are like unusual readings on a blood test – not necessarily problematic, but requiring further investigation. The minimal capital expenditure may indicate the business is "living off its reserves" rather than investing in future capacity.
3. Diagnosis
Overall Financial Condition: Healthy with Minor Concerns
Primary Findings:
The financial data reveals a business in excellent financial health, similar to a patient with strong vital signs but some lifestyle factors worth reviewing:
-
Strong Cash Generation: The 70% increase in cash (£183,295 to £312,371) while maintaining profitability suggests excellent cash conversion. The business is generating more cash than it is deploying.
-
Conservative Capital Structure: With a debt-to-equity ratio of only 0.32:1 and no hire purchase liabilities remaining, the company has significant borrowing capacity if needed for growth opportunities.
-
Asset Aging: Fixed assets have decreased from £60,554 to £29,982 primarily through depreciation, with only £90 of additions. Motor vehicles (£26,937 net book value) and computer equipment (£2,917 net book value) may need replacement in the near future. This is like an aging physical that suggests the patient may need to invest in their health soon.
-
Balance Sheet Opacity: The "other debtors" (£68,420) and "other creditors" (£25,947) are significant items that lack transparency in filleted accounts. These could represent related-party transactions, tax provisions, or operational items that warrant understanding.
-
Workforce Growth: Employee numbers increased from 5 to 6, suggesting the business is expanding its capacity, which is positive.
-
Long-term Stability: The 10-year track record shows the company has navigated economic cycles (including COVID-19 in 2020-2021) while maintaining net assets above £240,000 throughout – demonstrating resilience akin to a strong immune system.
Symptom Analysis Summary:
| Symptom | Severity | Notes |
|---|---|---|
| High cash reserves | Low (positive) | Could indicate under-deployment of capital |
| Minimal capital expenditure | Medium | May impact future competitiveness |
| Other debtors/creditors | Medium | Requires understanding of composition |
| Increasing tax liabilities | Low | Likely reflects profitability – positive sign |
| Declining trade debtors | Low (positive) | May indicate improved collection or timing |
4. Recommendations
Immediate Actions (0-3 months):
-
Investigate Balance Sheet Composition: Request management accounts to understand the nature of "other debtors" (£68,420) and "other creditors" (£25,947). These represent 17.8% and 6.8% of total assets respectively and should be clearly understood.
-
Capital Expenditure Planning: Review the condition and remaining useful life of motor vehicles (£26,937 net book value) and computer equipment. Develop a replacement schedule to avoid sudden large capital outlays.
Medium-term Actions (3-12 months):
-
Cash Deployment Strategy: With £312,371 in cash (81% of total assets), consider: - Whether excess cash should be invested for better returns - Whether dividend payments to shareholders are appropriate - Whether strategic acquisitions or business expansion should be pursued - This is like advising a patient with excellent reserves to ensure they're using their energy effectively
-
Review Working Capital Efficiency: While the current ratio is excellent, assess whether the high cash position is optimal or whether some current assets could be deployed more productively.
Long-term Considerations (12+ months):
-
Succession Planning: With the company being 23 years old and key individuals named as PSCs and officers, ensure robust succession and business continuity plans are in place.
-
Growth Strategy Evaluation: The company appears to have the financial capacity for growth. Consider whether the current business model and market position support expansion, and whether additional investment would enhance long-term value.
-
Pension Obligations: The accounts mention a defined contribution pension scheme. Ensure contributions are being made in line with auto-enrolment requirements and that the scheme is operating effectively.
Financial Health Trend Analysis
| Year | Net Assets | Cash | Current Ratio | Assessment |
|---|---|---|---|---|
| 2016 | £218,244 | £182,812 | ~4.4:1 | Healthy |
| 2017 | £297,623 | £216,178 | ~4.5:1 | Strong growth |
| 2018 | £274,773 | £199,639 | ~5.0:1 | Slight contraction |
| 2019 | £280,687 | £230,426 | ~4.6:1 | Recovery |
| 2020 | £328,195 | £317,121 | ~3.8:1 | Peak cash |
| 2021 | £256,106 | £183,655 | ~3.6:1 | COVID impact |
| 2022 | £293,453 | £187,261 | ~3.8:1 | Recovery |
| 2023 | £260,563 | £166,480 | ~3.6:1 | Dip |
| 2024 | £248,825 | £183,295 | ~3.3:1 | Trough |
| 2025 | £309,730 | £312,371 | ~3.9:1 | Strong recovery |
The trend shows resilience through economic cycles, with the company consistently maintaining strong liquidity and a substantial equity base.
Prognosis
Future Financial Outlook: Positive
The company is well-positioned to weather economic uncertainty, with substantial cash reserves and minimal debt obligations. The primary risk is not financial distress but rather the opportunity cost of holding excessive cash reserves that could be deployed more productively.
The elimination of hire purchase commitments, strong cash generation, and growing profitability suggest the business is entering a phase where strategic decisions about capital allocation will be important. Like a healthy patient with excellent fitness levels, the question is not whether they can survive, but how they choose to thrive.
The main watchpoints are: - Understanding the composition of "other" balance sheet items - Ensuring adequate reinvestment in business assets - Strategic deployment of excess cash reserves